Review





Similar Products

94
MedChemExpress recombinant stat1 proteins
Recombinant Stat1 Proteins, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/STAT1%2C+Human/pm41763198-307-0-6
Average 94 stars, based on 1 article reviews
recombinant stat1 proteins - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
TargetMol stat1 inhibitor fludarabine
NGP controls the expression of iNOS/NO by regulating the <t>JAK2/STAT1</t> signaling pathway. ( A ) Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS (10 μg/mL) for 6 h and lysed for RNA sequencing. The KEGG database was utilized to enrich signal pathways exhibiting significant differences. ( B ) Ngp NC /RAW and Ngp HI /RAW cells were stimulated with LPS for 6 h. The cells were harvested and subjected to CSP100 PLUS phosphorylation microarray analysis. ( C ) The Ngp NC /RAW and Ngp HI /RAW cells were treated without or with LPS for 6 and 12 h respectively. Western blotting analysis was performed to assess the phosphorylation levels of JAK2 and <t>STAT1.</t> ( D ) The Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS for 6 h and subjected for IP-MS to screen for the binding protein of NGP and verify the interaction. ( E ) The Ngp WT /RAW cells were treated without or with LPS for 6 h, harvested for Co-IP, and <t>STAT1</t> expression levels were quantified via grayscale intensity analysis. ( F – H ) The predicted structures of NGP and STAT1 were generated by Alphafold and subjected to GRAMM Web Server for molecular docking. ( F ) Molecular docking generic matching information. ( G ) Predicted binding sites between NGP and STAT1. ( H ) The protein–protein interaction cartoon model generated by PyMOL. (I-J) The phosphorylation levels in PBS- or LPS-treated Ngp NC /RAW and Ngp HI /RAW cells were examined by LSCM (Scale bar = 20 μm). (K-M) Ngp NC /RAW and Ngp HI /RAW cells were pre-treated without or with JAK2 inhibitor (10 μM), STAT1 inhibitor (50 μM), or control solution for 2 h and then stimulated without or with LPS for 12 h. The supernatants and cells were harvested for NO expression, Nos2 mRNA level and positive ratio of iNOS by aforementioned methods ( n = 3). (N–O) Ngp NC /RAW and Ngp. HI /RAW cells were transfected with scramble siRNA or STAT1 siRNA, respectively, followed by 12-h stimulation with PBS or LPS. The supernatants and cells were harvested for concurrent measurement of NO levels and Nos2 mRNA expression via Griess assay and qRT-PCR ( n = 3). The data represent the mean ± SEM of at least three independent experiments. Statistical analysis was performed using one-way ANOVA to compare the results. * p < 0.05
Stat1 Inhibitor Fludarabine, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/STAT1+Protein%2C+Human%2C+Recombinant/pmc12592619-27-6-12
Average 93 stars, based on 1 article reviews
stat1 inhibitor fludarabine - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Creative BioMart recombinant stat1
NGP controls the expression of iNOS/NO by regulating the <t>JAK2/STAT1</t> signaling pathway. ( A ) Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS (10 μg/mL) for 6 h and lysed for RNA sequencing. The KEGG database was utilized to enrich signal pathways exhibiting significant differences. ( B ) Ngp NC /RAW and Ngp HI /RAW cells were stimulated with LPS for 6 h. The cells were harvested and subjected to CSP100 PLUS phosphorylation microarray analysis. ( C ) The Ngp NC /RAW and Ngp HI /RAW cells were treated without or with LPS for 6 and 12 h respectively. Western blotting analysis was performed to assess the phosphorylation levels of JAK2 and <t>STAT1.</t> ( D ) The Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS for 6 h and subjected for IP-MS to screen for the binding protein of NGP and verify the interaction. ( E ) The Ngp WT /RAW cells were treated without or with LPS for 6 h, harvested for Co-IP, and <t>STAT1</t> expression levels were quantified via grayscale intensity analysis. ( F – H ) The predicted structures of NGP and STAT1 were generated by Alphafold and subjected to GRAMM Web Server for molecular docking. ( F ) Molecular docking generic matching information. ( G ) Predicted binding sites between NGP and STAT1. ( H ) The protein–protein interaction cartoon model generated by PyMOL. (I-J) The phosphorylation levels in PBS- or LPS-treated Ngp NC /RAW and Ngp HI /RAW cells were examined by LSCM (Scale bar = 20 μm). (K-M) Ngp NC /RAW and Ngp HI /RAW cells were pre-treated without or with JAK2 inhibitor (10 μM), STAT1 inhibitor (50 μM), or control solution for 2 h and then stimulated without or with LPS for 12 h. The supernatants and cells were harvested for NO expression, Nos2 mRNA level and positive ratio of iNOS by aforementioned methods ( n = 3). (N–O) Ngp NC /RAW and Ngp. HI /RAW cells were transfected with scramble siRNA or STAT1 siRNA, respectively, followed by 12-h stimulation with PBS or LPS. The supernatants and cells were harvested for concurrent measurement of NO levels and Nos2 mRNA expression via Griess assay and qRT-PCR ( n = 3). The data represent the mean ± SEM of at least three independent experiments. Statistical analysis was performed using one-way ANOVA to compare the results. * p < 0.05
Recombinant Stat1, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/Recombinant+Human+STAT1/pm42547268-295-31-33
Average 94 stars, based on 1 article reviews
recombinant stat1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology recombinant human stat1 protein
a A scatter plot showing differential gene expression in oHSV-GFP-infected U-251 MG cells treated with or without LRRK2-IN-1 (LRRK2i). U-251 MG cells were pretreated with LRRK2i (2.5 µM) or left untreated for 4 h, followed by infection with oHSV-GFP (MOI = 0.25 PFU/cell) for 4 h. RNA-Seq was used to assess differentially expressed genes among the treated cells. Blue dots represent genes significantly downregulated by LRRK2i during infection, and red dots represent genes significantly upregulated by LRRK2i during infection. b A heatmap showing the expression patterns of differentially expressed genes belonging to the “response to virus” category. The normalized expression values (Log 2 (TPM + 1)) in the heatmap depict the mean across three biological replicates. c GO enrichment analysis showing the top eight most enriched pathways downregulated by LRRK2i in oHSV-GFP-infected U-251 MG cells. d U-251 MG and U-87 MG cell lines were treated with LRRK2-IN-1 (2.5 μM) for 4 h, followed by IFNα and anti-IFNR1 (α-IFNR1) for an additional 4 h, and then infected with oHSV-GFP (MOI = 0.25 PFU/cell). Cell viability was determined 48 h post-infection. e Western blot analysis of <t>p-STAT1,</t> STAT1, and β-actin in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFNα served as a positive control. The samples derive from the same experiment but different gels for p-STAT1, another for STAT1 and another for actin were processed in parallel. f p-STAT1 and STAT1 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments corresponding to Fig. 4e. g RT‒qPCR analysis of the expression of the indicated IFN-stimulated gene transcript expression in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 12 h post-infection. h Western blot analysis of the indicated IFN-stimulated proteins (IFI16 and IRF9) in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFI16 and IRF9 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments. The samples derive from the same experiment but different gels for IFI16, another for IRF9 and another for actin were processed in parallel. The data are presented as the mean ± SD from two independent experiments ( d ) or three independent experiments ( d , f – h ), and P values were calculated using an ordinary one-way ANOVA ( d , f – h ).
Recombinant Human Stat1 Protein, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/Recombinant+human+STAT1+Protein/pmc13066370-435-0-4
Average 94 stars, based on 1 article reviews
recombinant human stat1 protein - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress d8375 recombinant stat1 protein mce hy p73628
a A scatter plot showing differential gene expression in oHSV-GFP-infected U-251 MG cells treated with or without LRRK2-IN-1 (LRRK2i). U-251 MG cells were pretreated with LRRK2i (2.5 µM) or left untreated for 4 h, followed by infection with oHSV-GFP (MOI = 0.25 PFU/cell) for 4 h. RNA-Seq was used to assess differentially expressed genes among the treated cells. Blue dots represent genes significantly downregulated by LRRK2i during infection, and red dots represent genes significantly upregulated by LRRK2i during infection. b A heatmap showing the expression patterns of differentially expressed genes belonging to the “response to virus” category. The normalized expression values (Log 2 (TPM + 1)) in the heatmap depict the mean across three biological replicates. c GO enrichment analysis showing the top eight most enriched pathways downregulated by LRRK2i in oHSV-GFP-infected U-251 MG cells. d U-251 MG and U-87 MG cell lines were treated with LRRK2-IN-1 (2.5 μM) for 4 h, followed by IFNα and anti-IFNR1 (α-IFNR1) for an additional 4 h, and then infected with oHSV-GFP (MOI = 0.25 PFU/cell). Cell viability was determined 48 h post-infection. e Western blot analysis of <t>p-STAT1,</t> STAT1, and β-actin in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFNα served as a positive control. The samples derive from the same experiment but different gels for p-STAT1, another for STAT1 and another for actin were processed in parallel. f p-STAT1 and STAT1 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments corresponding to Fig. 4e. g RT‒qPCR analysis of the expression of the indicated IFN-stimulated gene transcript expression in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 12 h post-infection. h Western blot analysis of the indicated IFN-stimulated proteins (IFI16 and IRF9) in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFI16 and IRF9 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments. The samples derive from the same experiment but different gels for IFI16, another for IRF9 and another for actin were processed in parallel. The data are presented as the mean ± SD from two independent experiments ( d ) or three independent experiments ( d , f – h ), and P values were calculated using an ordinary one-way ANOVA ( d , f – h ).
D8375 Recombinant Stat1 Protein Mce Hy P73628, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/STAT1%2C+Human/pm41763198-212-238-242
Average 94 stars, based on 1 article reviews
d8375 recombinant stat1 protein mce hy p73628 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology recombinant stat1 protein
A Coomassie Brilliant Blue staining of SDS-PAGE gels after the DARTS experiment; bands with molecular weights around 80 kDa were protected by FFD. Mass spectrum of <t>STAT1.</t> B Western blot analysis of STAT1 protein levels in Human normal chondrocytes treated with increasing concentrations of FFD (0, 10, 50, 100 μM) under proteolytic digestion. C Human normal chondrocytes were digested with different concentrations of proteases with or without FFD, after which STAT1 protein levels were determined using Western blotting. D , F Human normal chondrocyte lysates were denatured at different temperatures with or without FFD, after which STAT1 protein levels were assessed by Western blotting and Image J software (n = 3). E , G Isothermal dose-response curve (n = 3). H MST assay showing affinity between FFD and purified His-tagged STAT1 protein. I Molecular docking simulation of the interaction of FFD with human STAT1. STAT1 is shown in cyan. Hydrogen bonding is indicated by green dashed lines in 3D plots, with values indicating the bonding distances. Hydrogen bonding is indicated by purple arrows in 2D plots. Hydrophobic amino acids are shown in green, acidic amino acids in red, basic amino acids in blue, and uncharged polar amino acids in cyan. J Human normal chondrocytes were transfected using a myc-tagged STAT1 point mutant plasmid. Western blotting was used to assess MYC signalling after the DARTS experiment. K , L STAT1 protein expression in chondrocytes from healthy individuals and OA patients shown by Western blotting, and quantified using Image J (n = 6). M , N Protein expression of p-STAT1 (S727) in the ACLT animal model was assessed by immunohistochemical staining. Scale bars = 200 µm (left panel) and 100 µm (right panel). Quantitative analysis of immunohistochemical staining using Image J (n = 6). O , P OA chondrocytes were transiently transfected with pcDNA4, STAT1, or STAT1β plasmids for 24 h, after which they were treated for 30 min with or without FFD (10 µM). Western blotting and quantification of phosphorylated Smad2 (n = 3). Q OA chondrocytes were transiently transfected with pcDNA4 STAT1α plasmids for 24 h, after which they were treated for 24 h with or without FFD (10 µM). mRNA levels of ACAN and COL2A1 were measured using qRT-PCR (n = 3). R , S Knockdown of STAT1 in OA chondrocytes by siRNA, after which the cells were treated for 30 min with or without FFD (10 µM). Smad2 phosphorylation was assessed by immunoblotting. Densitometric analysis of the gels by Image J (n = 3). T Co-immunoprecipitation (Co-IP) was used to assess STAT1 interaction with ALK5 with or without FFD treatment. Significant differences are indicated as follows: * P < 0:05, ** P < 0:01, and *** P < 0:001; ns: not statistically significant.
Recombinant Stat1 Protein, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/Recombinant+human+STAT1+Protein/pmc12540828-423-1-5
Average 94 stars, based on 1 article reviews
recombinant stat1 protein - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
MedChemExpress recombinant human stat1
(A) Immunoblot analysis of <t>STAT1</t> and STAT2 protein levels in PARP7 WT and KO MEF cells. The experiment was repeated twice. (B) Co-immunoprecipitation (coIP) analysis showing that STAT1 and STAT2 interact with PARP7. FLAG-PARP7 was ectopically expressed in HEK293T cells. FLAG-PARP7 was immunoprecipitated and then blotted for endogenous STAT1 and STAT2. The experiment was repeated twice. (C and D) Immunoblot analysis of ADP-ribosylated STAT1 (C) and STAT2 (D) in PARP7 WT and KO MEF cells. Cells were lysed in the presence of biotin-NAD + or NAD + . Proteins that were ADP-ribosylated by biotin-NAD + were pulled down with streptavidin beads and then blotted for STAT1 or STAT2. Samples treated with NAD + were used as a negative control. Both experiments were repeated three times. (E) PARP7 WT, but not the H532A mutant, ADP-ribosylates STAT1. GFP-tagged empty vector (EV), WT PARP7, or the H532 mutant were co-transfected with FLAG-STAT1 into HEK293T cells. FLAG-STAT1 was pulled down to detect interaction with PARP7 (blotted with GFP antibody) and ADP-ribosylation (blotted with ADP-ribose antibody). The experiment was repeated twice. See also .
Recombinant Human Stat1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/STAT1%2C+Human/pmc12509220-343-0-5
Average 93 stars, based on 1 article reviews
recombinant human stat1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
MedChemExpress gst stat1 recombinant proteins
(A) Immunoblot analysis of <t>STAT1</t> and STAT2 protein levels in PARP7 WT and KO MEF cells. The experiment was repeated twice. (B) Co-immunoprecipitation (coIP) analysis showing that STAT1 and STAT2 interact with PARP7. FLAG-PARP7 was ectopically expressed in HEK293T cells. FLAG-PARP7 was immunoprecipitated and then blotted for endogenous STAT1 and STAT2. The experiment was repeated twice. (C and D) Immunoblot analysis of ADP-ribosylated STAT1 (C) and STAT2 (D) in PARP7 WT and KO MEF cells. Cells were lysed in the presence of biotin-NAD + or NAD + . Proteins that were ADP-ribosylated by biotin-NAD + were pulled down with streptavidin beads and then blotted for STAT1 or STAT2. Samples treated with NAD + were used as a negative control. Both experiments were repeated three times. (E) PARP7 WT, but not the H532A mutant, ADP-ribosylates STAT1. GFP-tagged empty vector (EV), WT PARP7, or the H532 mutant were co-transfected with FLAG-STAT1 into HEK293T cells. FLAG-STAT1 was pulled down to detect interaction with PARP7 (blotted with GFP antibody) and ADP-ribosylation (blotted with ADP-ribose antibody). The experiment was repeated twice. See also .
Gst Stat1 Recombinant Proteins, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+stat1/STAT1%2C+Human/pm40195316-357-0-3
Average 94 stars, based on 1 article reviews
gst stat1 recombinant proteins - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


NGP controls the expression of iNOS/NO by regulating the JAK2/STAT1 signaling pathway. ( A ) Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS (10 μg/mL) for 6 h and lysed for RNA sequencing. The KEGG database was utilized to enrich signal pathways exhibiting significant differences. ( B ) Ngp NC /RAW and Ngp HI /RAW cells were stimulated with LPS for 6 h. The cells were harvested and subjected to CSP100 PLUS phosphorylation microarray analysis. ( C ) The Ngp NC /RAW and Ngp HI /RAW cells were treated without or with LPS for 6 and 12 h respectively. Western blotting analysis was performed to assess the phosphorylation levels of JAK2 and STAT1. ( D ) The Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS for 6 h and subjected for IP-MS to screen for the binding protein of NGP and verify the interaction. ( E ) The Ngp WT /RAW cells were treated without or with LPS for 6 h, harvested for Co-IP, and STAT1 expression levels were quantified via grayscale intensity analysis. ( F – H ) The predicted structures of NGP and STAT1 were generated by Alphafold and subjected to GRAMM Web Server for molecular docking. ( F ) Molecular docking generic matching information. ( G ) Predicted binding sites between NGP and STAT1. ( H ) The protein–protein interaction cartoon model generated by PyMOL. (I-J) The phosphorylation levels in PBS- or LPS-treated Ngp NC /RAW and Ngp HI /RAW cells were examined by LSCM (Scale bar = 20 μm). (K-M) Ngp NC /RAW and Ngp HI /RAW cells were pre-treated without or with JAK2 inhibitor (10 μM), STAT1 inhibitor (50 μM), or control solution for 2 h and then stimulated without or with LPS for 12 h. The supernatants and cells were harvested for NO expression, Nos2 mRNA level and positive ratio of iNOS by aforementioned methods ( n = 3). (N–O) Ngp NC /RAW and Ngp. HI /RAW cells were transfected with scramble siRNA or STAT1 siRNA, respectively, followed by 12-h stimulation with PBS or LPS. The supernatants and cells were harvested for concurrent measurement of NO levels and Nos2 mRNA expression via Griess assay and qRT-PCR ( n = 3). The data represent the mean ± SEM of at least three independent experiments. Statistical analysis was performed using one-way ANOVA to compare the results. * p < 0.05

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Neutrophilic granule protein promotes lipopolysaccharide-induced iNOS/NO expression via JAK2/STAT1 signaling pathway and augments bacteria clearance of macrophages

doi: 10.1007/s00018-025-05865-9

Figure Lengend Snippet: NGP controls the expression of iNOS/NO by regulating the JAK2/STAT1 signaling pathway. ( A ) Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS (10 μg/mL) for 6 h and lysed for RNA sequencing. The KEGG database was utilized to enrich signal pathways exhibiting significant differences. ( B ) Ngp NC /RAW and Ngp HI /RAW cells were stimulated with LPS for 6 h. The cells were harvested and subjected to CSP100 PLUS phosphorylation microarray analysis. ( C ) The Ngp NC /RAW and Ngp HI /RAW cells were treated without or with LPS for 6 and 12 h respectively. Western blotting analysis was performed to assess the phosphorylation levels of JAK2 and STAT1. ( D ) The Ngp NC /RAW and Ngp HI /RAW cells were treated with LPS for 6 h and subjected for IP-MS to screen for the binding protein of NGP and verify the interaction. ( E ) The Ngp WT /RAW cells were treated without or with LPS for 6 h, harvested for Co-IP, and STAT1 expression levels were quantified via grayscale intensity analysis. ( F – H ) The predicted structures of NGP and STAT1 were generated by Alphafold and subjected to GRAMM Web Server for molecular docking. ( F ) Molecular docking generic matching information. ( G ) Predicted binding sites between NGP and STAT1. ( H ) The protein–protein interaction cartoon model generated by PyMOL. (I-J) The phosphorylation levels in PBS- or LPS-treated Ngp NC /RAW and Ngp HI /RAW cells were examined by LSCM (Scale bar = 20 μm). (K-M) Ngp NC /RAW and Ngp HI /RAW cells were pre-treated without or with JAK2 inhibitor (10 μM), STAT1 inhibitor (50 μM), or control solution for 2 h and then stimulated without or with LPS for 12 h. The supernatants and cells were harvested for NO expression, Nos2 mRNA level and positive ratio of iNOS by aforementioned methods ( n = 3). (N–O) Ngp NC /RAW and Ngp. HI /RAW cells were transfected with scramble siRNA or STAT1 siRNA, respectively, followed by 12-h stimulation with PBS or LPS. The supernatants and cells were harvested for concurrent measurement of NO levels and Nos2 mRNA expression via Griess assay and qRT-PCR ( n = 3). The data represent the mean ± SEM of at least three independent experiments. Statistical analysis was performed using one-way ANOVA to compare the results. * p < 0.05

Article Snippet: The JAK2 inhibitor (Ruxolitinib) and the STAT1 inhibitor (Fludarabine) were purchased from TargetMol (Boston, USA).

Techniques: Expressing, RNA Sequencing, Phospho-proteomics, Microarray, Analysis, Western Blot, Protein-Protein interactions, Binding Assay, Co-Immunoprecipitation Assay, Generated, Docking Assay, Control, Transfection, Griess Assay, Quantitative RT-PCR, Immunofluorescence

a A scatter plot showing differential gene expression in oHSV-GFP-infected U-251 MG cells treated with or without LRRK2-IN-1 (LRRK2i). U-251 MG cells were pretreated with LRRK2i (2.5 µM) or left untreated for 4 h, followed by infection with oHSV-GFP (MOI = 0.25 PFU/cell) for 4 h. RNA-Seq was used to assess differentially expressed genes among the treated cells. Blue dots represent genes significantly downregulated by LRRK2i during infection, and red dots represent genes significantly upregulated by LRRK2i during infection. b A heatmap showing the expression patterns of differentially expressed genes belonging to the “response to virus” category. The normalized expression values (Log 2 (TPM + 1)) in the heatmap depict the mean across three biological replicates. c GO enrichment analysis showing the top eight most enriched pathways downregulated by LRRK2i in oHSV-GFP-infected U-251 MG cells. d U-251 MG and U-87 MG cell lines were treated with LRRK2-IN-1 (2.5 μM) for 4 h, followed by IFNα and anti-IFNR1 (α-IFNR1) for an additional 4 h, and then infected with oHSV-GFP (MOI = 0.25 PFU/cell). Cell viability was determined 48 h post-infection. e Western blot analysis of p-STAT1, STAT1, and β-actin in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFNα served as a positive control. The samples derive from the same experiment but different gels for p-STAT1, another for STAT1 and another for actin were processed in parallel. f p-STAT1 and STAT1 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments corresponding to Fig. 4e. g RT‒qPCR analysis of the expression of the indicated IFN-stimulated gene transcript expression in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 12 h post-infection. h Western blot analysis of the indicated IFN-stimulated proteins (IFI16 and IRF9) in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFI16 and IRF9 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments. The samples derive from the same experiment but different gels for IFI16, another for IRF9 and another for actin were processed in parallel. The data are presented as the mean ± SD from two independent experiments ( d ) or three independent experiments ( d , f – h ), and P values were calculated using an ordinary one-way ANOVA ( d , f – h ).

Journal: Nature Communications

Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

doi: 10.1038/s41467-026-70132-9

Figure Lengend Snippet: a A scatter plot showing differential gene expression in oHSV-GFP-infected U-251 MG cells treated with or without LRRK2-IN-1 (LRRK2i). U-251 MG cells were pretreated with LRRK2i (2.5 µM) or left untreated for 4 h, followed by infection with oHSV-GFP (MOI = 0.25 PFU/cell) for 4 h. RNA-Seq was used to assess differentially expressed genes among the treated cells. Blue dots represent genes significantly downregulated by LRRK2i during infection, and red dots represent genes significantly upregulated by LRRK2i during infection. b A heatmap showing the expression patterns of differentially expressed genes belonging to the “response to virus” category. The normalized expression values (Log 2 (TPM + 1)) in the heatmap depict the mean across three biological replicates. c GO enrichment analysis showing the top eight most enriched pathways downregulated by LRRK2i in oHSV-GFP-infected U-251 MG cells. d U-251 MG and U-87 MG cell lines were treated with LRRK2-IN-1 (2.5 μM) for 4 h, followed by IFNα and anti-IFNR1 (α-IFNR1) for an additional 4 h, and then infected with oHSV-GFP (MOI = 0.25 PFU/cell). Cell viability was determined 48 h post-infection. e Western blot analysis of p-STAT1, STAT1, and β-actin in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFNα served as a positive control. The samples derive from the same experiment but different gels for p-STAT1, another for STAT1 and another for actin were processed in parallel. f p-STAT1 and STAT1 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments corresponding to Fig. 4e. g RT‒qPCR analysis of the expression of the indicated IFN-stimulated gene transcript expression in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 12 h post-infection. h Western blot analysis of the indicated IFN-stimulated proteins (IFI16 and IRF9) in GBM cell lines infected with oHSV-GFP or mock-infected, either with or without LRRK2-IN-1 (2.5 µM), 48 h post-infection. IFI16 and IRF9 expression levels were quantified by densitometric analysis of bands from three independent Western blot experiments. The samples derive from the same experiment but different gels for IFI16, another for IRF9 and another for actin were processed in parallel. The data are presented as the mean ± SD from two independent experiments ( d ) or three independent experiments ( d , f – h ), and P values were calculated using an ordinary one-way ANOVA ( d , f – h ).

Article Snippet: Recombinant human STAT1 protein (ABclonal, RP01251) was incubated with active, baculovirus-expressed LRRK2 protein (Thermo Fisher Scientific, A15197 ) in 1 × kinase buffer (Cell Signaling Technologies, 9802S) containing 200 μM ATP (Cell Signaling Technologies, 9804S) for 30 min at 30 °C.

Techniques: Gene Expression, Infection, RNA Sequencing, Expressing, Virus, Western Blot, Positive Control

a Anti-myc immunoprecipitates prepared from 293 T cells transfected with the indicated plasmids were subjected to SDS‒PAGE and blotted with the indicated antibodies. The samples derive from the same experiment but different gels for Myc and another for STAT1 were processed in parallel. b Endogenous LRRK2 and STAT1 complexes in U-118 MG cells were isolated by co-immunoprecipitation (co-IP) and detected using anti-LRRK2 antibodies. The samples derive from the same experiment but different gels for LRRK2 and another for STAT1 were processed in parallel. c The interactions between STAT1-Flag and Myc-LRRK2 mutants were detected by a co-IP assay. FL, full-length. The samples derive from the same experiment but different gels for Myc and another for Flag were processed in parallel. d , e The interactions between Myc-LRRK2 and STAT1-HA truncations were detected by a co-IP assay. The samples derive from the same experiment but different gels for Myc and another for HA were processed in parallel. f STAT1-His proteins were incubated with human FL LRRK2 proteins in the presence of ATP. The reaction products were analyzed with the indicated antibodies. CD300A proteins served as a negative control. The samples derive from the same experiment but different gels for Flag and another for His were processed in parallel. g , h 293 T cells were cotransfected with Flag-STAT1 and LRRK2 in the presence or absence of LRRK2-IN-1, and the phosphorylation of STAT1 was analyzed by western blot analysis. The samples derive from the same experiment but different gels for STAT1, another for p-STAT1 701 and another for p-STAT1 727 were processed in parallel. i 293 T cells were cotransfected with Flag-STAT1 and each LRRK2 mutant, either in the presence or absence of LRRK2-IN-1, and STAT1 phosphorylation was assessed via western blot analysis. The samples derive from the same experiment but different gels for STAT1, another for p-STAT1 701 and another for GAPDH were processed in parallel. j Western blotting was performed to assess and quantify phosphorylated STAT1 and HSV-derived GFP in U-87 MG cells treated with fludarabine (10 µM) for 4 h, either in the presence or absence of LRRK2-IN-1, followed by infection with oHSV-GFP (MOI = 1 PFU/cell). The samples derive from the same experiment but different gels for STAT1 and GFP, another for p-STAT1 701 and another for actin were processed in parallel. k Western blotting was performed to assess and quantify phosphorylated STAT1 and HSV-derived GFP in GBM-1 cells. Cells transfected with EV, LRRK2 or LRRK2 D1994A were infected with oHSV-GFP (MOI = 0.5 PFU/cell), with or without LRRK2-IN-1. The samples derive from the same experiment but different gels for STAT1 and GFP, another for p-STAT1 701 and another for actin were processed in parallel. l Western blotting was performed to assess and quantify phosphorylated TBK1, phosphorylated LRRK2, phosphorylated Rab10, and phosphorylated STAT1 in BX795 (10 µM)-treated U-87 cells following infection with oHSV-GFP (MOI = 0.5 PFU/cell). The samples derive from the same experiment but different gels for p-TBK1, another for p-LRRK2, another for LRRK2, another for p-Rab10 and p-STAT1, another for STAT1 and another for actin were processed in parallel. Western blot analyses were independently repeated twice for panels ( a – d and f )and three times for panels ( e , g and i – l ), with similar results. The data are presented as the mean ± SD from three independent experiments ( h – l ), and P values were calculated using an ordinary one-way ANOVA ( h – l ).

Journal: Nature Communications

Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

doi: 10.1038/s41467-026-70132-9

Figure Lengend Snippet: a Anti-myc immunoprecipitates prepared from 293 T cells transfected with the indicated plasmids were subjected to SDS‒PAGE and blotted with the indicated antibodies. The samples derive from the same experiment but different gels for Myc and another for STAT1 were processed in parallel. b Endogenous LRRK2 and STAT1 complexes in U-118 MG cells were isolated by co-immunoprecipitation (co-IP) and detected using anti-LRRK2 antibodies. The samples derive from the same experiment but different gels for LRRK2 and another for STAT1 were processed in parallel. c The interactions between STAT1-Flag and Myc-LRRK2 mutants were detected by a co-IP assay. FL, full-length. The samples derive from the same experiment but different gels for Myc and another for Flag were processed in parallel. d , e The interactions between Myc-LRRK2 and STAT1-HA truncations were detected by a co-IP assay. The samples derive from the same experiment but different gels for Myc and another for HA were processed in parallel. f STAT1-His proteins were incubated with human FL LRRK2 proteins in the presence of ATP. The reaction products were analyzed with the indicated antibodies. CD300A proteins served as a negative control. The samples derive from the same experiment but different gels for Flag and another for His were processed in parallel. g , h 293 T cells were cotransfected with Flag-STAT1 and LRRK2 in the presence or absence of LRRK2-IN-1, and the phosphorylation of STAT1 was analyzed by western blot analysis. The samples derive from the same experiment but different gels for STAT1, another for p-STAT1 701 and another for p-STAT1 727 were processed in parallel. i 293 T cells were cotransfected with Flag-STAT1 and each LRRK2 mutant, either in the presence or absence of LRRK2-IN-1, and STAT1 phosphorylation was assessed via western blot analysis. The samples derive from the same experiment but different gels for STAT1, another for p-STAT1 701 and another for GAPDH were processed in parallel. j Western blotting was performed to assess and quantify phosphorylated STAT1 and HSV-derived GFP in U-87 MG cells treated with fludarabine (10 µM) for 4 h, either in the presence or absence of LRRK2-IN-1, followed by infection with oHSV-GFP (MOI = 1 PFU/cell). The samples derive from the same experiment but different gels for STAT1 and GFP, another for p-STAT1 701 and another for actin were processed in parallel. k Western blotting was performed to assess and quantify phosphorylated STAT1 and HSV-derived GFP in GBM-1 cells. Cells transfected with EV, LRRK2 or LRRK2 D1994A were infected with oHSV-GFP (MOI = 0.5 PFU/cell), with or without LRRK2-IN-1. The samples derive from the same experiment but different gels for STAT1 and GFP, another for p-STAT1 701 and another for actin were processed in parallel. l Western blotting was performed to assess and quantify phosphorylated TBK1, phosphorylated LRRK2, phosphorylated Rab10, and phosphorylated STAT1 in BX795 (10 µM)-treated U-87 cells following infection with oHSV-GFP (MOI = 0.5 PFU/cell). The samples derive from the same experiment but different gels for p-TBK1, another for p-LRRK2, another for LRRK2, another for p-Rab10 and p-STAT1, another for STAT1 and another for actin were processed in parallel. Western blot analyses were independently repeated twice for panels ( a – d and f )and three times for panels ( e , g and i – l ), with similar results. The data are presented as the mean ± SD from three independent experiments ( h – l ), and P values were calculated using an ordinary one-way ANOVA ( h – l ).

Article Snippet: Recombinant human STAT1 protein (ABclonal, RP01251) was incubated with active, baculovirus-expressed LRRK2 protein (Thermo Fisher Scientific, A15197 ) in 1 × kinase buffer (Cell Signaling Technologies, 9802S) containing 200 μM ATP (Cell Signaling Technologies, 9804S) for 30 min at 30 °C.

Techniques: Transfection, Isolation, Immunoprecipitation, Co-Immunoprecipitation Assay, Incubation, Negative Control, Phospho-proteomics, Western Blot, Mutagenesis, Derivative Assay, Infection

A Coomassie Brilliant Blue staining of SDS-PAGE gels after the DARTS experiment; bands with molecular weights around 80 kDa were protected by FFD. Mass spectrum of STAT1. B Western blot analysis of STAT1 protein levels in Human normal chondrocytes treated with increasing concentrations of FFD (0, 10, 50, 100 μM) under proteolytic digestion. C Human normal chondrocytes were digested with different concentrations of proteases with or without FFD, after which STAT1 protein levels were determined using Western blotting. D , F Human normal chondrocyte lysates were denatured at different temperatures with or without FFD, after which STAT1 protein levels were assessed by Western blotting and Image J software (n = 3). E , G Isothermal dose-response curve (n = 3). H MST assay showing affinity between FFD and purified His-tagged STAT1 protein. I Molecular docking simulation of the interaction of FFD with human STAT1. STAT1 is shown in cyan. Hydrogen bonding is indicated by green dashed lines in 3D plots, with values indicating the bonding distances. Hydrogen bonding is indicated by purple arrows in 2D plots. Hydrophobic amino acids are shown in green, acidic amino acids in red, basic amino acids in blue, and uncharged polar amino acids in cyan. J Human normal chondrocytes were transfected using a myc-tagged STAT1 point mutant plasmid. Western blotting was used to assess MYC signalling after the DARTS experiment. K , L STAT1 protein expression in chondrocytes from healthy individuals and OA patients shown by Western blotting, and quantified using Image J (n = 6). M , N Protein expression of p-STAT1 (S727) in the ACLT animal model was assessed by immunohistochemical staining. Scale bars = 200 µm (left panel) and 100 µm (right panel). Quantitative analysis of immunohistochemical staining using Image J (n = 6). O , P OA chondrocytes were transiently transfected with pcDNA4, STAT1, or STAT1β plasmids for 24 h, after which they were treated for 30 min with or without FFD (10 µM). Western blotting and quantification of phosphorylated Smad2 (n = 3). Q OA chondrocytes were transiently transfected with pcDNA4 STAT1α plasmids for 24 h, after which they were treated for 24 h with or without FFD (10 µM). mRNA levels of ACAN and COL2A1 were measured using qRT-PCR (n = 3). R , S Knockdown of STAT1 in OA chondrocytes by siRNA, after which the cells were treated for 30 min with or without FFD (10 µM). Smad2 phosphorylation was assessed by immunoblotting. Densitometric analysis of the gels by Image J (n = 3). T Co-immunoprecipitation (Co-IP) was used to assess STAT1 interaction with ALK5 with or without FFD treatment. Significant differences are indicated as follows: * P < 0:05, ** P < 0:01, and *** P < 0:001; ns: not statistically significant.

Journal: Cell Death Discovery

Article Title: Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism

doi: 10.1038/s41420-025-02754-9

Figure Lengend Snippet: A Coomassie Brilliant Blue staining of SDS-PAGE gels after the DARTS experiment; bands with molecular weights around 80 kDa were protected by FFD. Mass spectrum of STAT1. B Western blot analysis of STAT1 protein levels in Human normal chondrocytes treated with increasing concentrations of FFD (0, 10, 50, 100 μM) under proteolytic digestion. C Human normal chondrocytes were digested with different concentrations of proteases with or without FFD, after which STAT1 protein levels were determined using Western blotting. D , F Human normal chondrocyte lysates were denatured at different temperatures with or without FFD, after which STAT1 protein levels were assessed by Western blotting and Image J software (n = 3). E , G Isothermal dose-response curve (n = 3). H MST assay showing affinity between FFD and purified His-tagged STAT1 protein. I Molecular docking simulation of the interaction of FFD with human STAT1. STAT1 is shown in cyan. Hydrogen bonding is indicated by green dashed lines in 3D plots, with values indicating the bonding distances. Hydrogen bonding is indicated by purple arrows in 2D plots. Hydrophobic amino acids are shown in green, acidic amino acids in red, basic amino acids in blue, and uncharged polar amino acids in cyan. J Human normal chondrocytes were transfected using a myc-tagged STAT1 point mutant plasmid. Western blotting was used to assess MYC signalling after the DARTS experiment. K , L STAT1 protein expression in chondrocytes from healthy individuals and OA patients shown by Western blotting, and quantified using Image J (n = 6). M , N Protein expression of p-STAT1 (S727) in the ACLT animal model was assessed by immunohistochemical staining. Scale bars = 200 µm (left panel) and 100 µm (right panel). Quantitative analysis of immunohistochemical staining using Image J (n = 6). O , P OA chondrocytes were transiently transfected with pcDNA4, STAT1, or STAT1β plasmids for 24 h, after which they were treated for 30 min with or without FFD (10 µM). Western blotting and quantification of phosphorylated Smad2 (n = 3). Q OA chondrocytes were transiently transfected with pcDNA4 STAT1α plasmids for 24 h, after which they were treated for 24 h with or without FFD (10 µM). mRNA levels of ACAN and COL2A1 were measured using qRT-PCR (n = 3). R , S Knockdown of STAT1 in OA chondrocytes by siRNA, after which the cells were treated for 30 min with or without FFD (10 µM). Smad2 phosphorylation was assessed by immunoblotting. Densitometric analysis of the gels by Image J (n = 3). T Co-immunoprecipitation (Co-IP) was used to assess STAT1 interaction with ALK5 with or without FFD treatment. Significant differences are indicated as follows: * P < 0:05, ** P < 0:01, and *** P < 0:001; ns: not statistically significant.

Article Snippet: Purified recombinant STAT1 protein (RP01251; Abclonal) was labelled using the Protein Labelling Kit RED-NHS (NanoTemper, Beijing, China).

Techniques: Staining, SDS Page, Western Blot, Software, Purification, Transfection, Mutagenesis, Plasmid Preparation, Expressing, Animal Model, Immunohistochemical staining, Quantitative RT-PCR, Knockdown, Phospho-proteomics, Immunoprecipitation, Co-Immunoprecipitation Assay

A , B STAT1 knockdown via siRNA in Human normal chondrocytes, after which the cells were treated with or without (10 µM, 30 min); Smad2 phosphorylation was assessed via Western blot and quantified using Image J (n = 3). C qRT-PCR analysis of ACAN and COL2A1 mRNA levels in STAT1-silenced chondrocytes treated with or without FFD (10 µM, 24 h) (n = 3). D Pull-down of target proteins from human chondrocytes using FFD-conjugated Fe 3 O 4 beads, followed by mass spectrometry. E , F DARTS assay confirming FFD–Smad2 interaction. G , H CETSA demonstrating thermal stabilisation of Smad2 by FFD. I , J Isothermal dose-response assay showing Smad2 stabilisation by FFD, with Western blot and associated quantitative curve. K Surface plasmon resonance (SPR) assay assessing affinity between FFD and purified His-tagged Smad2 protein. L Molecular docking of FFD to Smad2 illustrating surface and 3D binding modes. M Western blot validation of siRNA-mediated Smad2 knockdown in human chondrocytes and C3H10T1/2 MSCs. N mRNA levels of ACAN , COL2A1 , and COMP in Human normal chondrocytes assessed via qRT-PCR (n = 3). O COMP protein levels in Human normal chondrocyte culture supernatants measured by ELISA (n = 3). P qRT-PCR analysis of ACAN , COL2A1 , and COMP mRNA levels in C3H10T1/2 MSCs (n = 3). Q , R Western blot and Image J quantification of SOX-9 protein levels in C3H10T1/2 MSCs (n = 3). S COMP protein levels in culture supernatants of C3H10T1/2 MSCs measured by ELISA (n = 3). Statistical significance: * P < 0:05, ** P < 0:01, and *** P < 0:001; ns not statistically significant.

Journal: Cell Death Discovery

Article Title: Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism

doi: 10.1038/s41420-025-02754-9

Figure Lengend Snippet: A , B STAT1 knockdown via siRNA in Human normal chondrocytes, after which the cells were treated with or without (10 µM, 30 min); Smad2 phosphorylation was assessed via Western blot and quantified using Image J (n = 3). C qRT-PCR analysis of ACAN and COL2A1 mRNA levels in STAT1-silenced chondrocytes treated with or without FFD (10 µM, 24 h) (n = 3). D Pull-down of target proteins from human chondrocytes using FFD-conjugated Fe 3 O 4 beads, followed by mass spectrometry. E , F DARTS assay confirming FFD–Smad2 interaction. G , H CETSA demonstrating thermal stabilisation of Smad2 by FFD. I , J Isothermal dose-response assay showing Smad2 stabilisation by FFD, with Western blot and associated quantitative curve. K Surface plasmon resonance (SPR) assay assessing affinity between FFD and purified His-tagged Smad2 protein. L Molecular docking of FFD to Smad2 illustrating surface and 3D binding modes. M Western blot validation of siRNA-mediated Smad2 knockdown in human chondrocytes and C3H10T1/2 MSCs. N mRNA levels of ACAN , COL2A1 , and COMP in Human normal chondrocytes assessed via qRT-PCR (n = 3). O COMP protein levels in Human normal chondrocyte culture supernatants measured by ELISA (n = 3). P qRT-PCR analysis of ACAN , COL2A1 , and COMP mRNA levels in C3H10T1/2 MSCs (n = 3). Q , R Western blot and Image J quantification of SOX-9 protein levels in C3H10T1/2 MSCs (n = 3). S COMP protein levels in culture supernatants of C3H10T1/2 MSCs measured by ELISA (n = 3). Statistical significance: * P < 0:05, ** P < 0:01, and *** P < 0:001; ns not statistically significant.

Article Snippet: Purified recombinant STAT1 protein (RP01251; Abclonal) was labelled using the Protein Labelling Kit RED-NHS (NanoTemper, Beijing, China).

Techniques: Knockdown, Phospho-proteomics, Western Blot, Quantitative RT-PCR, Mass Spectrometry, SPR Assay, Purification, Binding Assay, Biomarker Discovery, Enzyme-linked Immunosorbent Assay

(A) Immunoblot analysis of STAT1 and STAT2 protein levels in PARP7 WT and KO MEF cells. The experiment was repeated twice. (B) Co-immunoprecipitation (coIP) analysis showing that STAT1 and STAT2 interact with PARP7. FLAG-PARP7 was ectopically expressed in HEK293T cells. FLAG-PARP7 was immunoprecipitated and then blotted for endogenous STAT1 and STAT2. The experiment was repeated twice. (C and D) Immunoblot analysis of ADP-ribosylated STAT1 (C) and STAT2 (D) in PARP7 WT and KO MEF cells. Cells were lysed in the presence of biotin-NAD + or NAD + . Proteins that were ADP-ribosylated by biotin-NAD + were pulled down with streptavidin beads and then blotted for STAT1 or STAT2. Samples treated with NAD + were used as a negative control. Both experiments were repeated three times. (E) PARP7 WT, but not the H532A mutant, ADP-ribosylates STAT1. GFP-tagged empty vector (EV), WT PARP7, or the H532 mutant were co-transfected with FLAG-STAT1 into HEK293T cells. FLAG-STAT1 was pulled down to detect interaction with PARP7 (blotted with GFP antibody) and ADP-ribosylation (blotted with ADP-ribose antibody). The experiment was repeated twice. See also .

Journal: Cell reports

Article Title: PARP7 inhibition stabilizes STAT1/STAT2 and relieves experimental autoimmune encephalomyelitis in mice

doi: 10.1016/j.celrep.2025.116130

Figure Lengend Snippet: (A) Immunoblot analysis of STAT1 and STAT2 protein levels in PARP7 WT and KO MEF cells. The experiment was repeated twice. (B) Co-immunoprecipitation (coIP) analysis showing that STAT1 and STAT2 interact with PARP7. FLAG-PARP7 was ectopically expressed in HEK293T cells. FLAG-PARP7 was immunoprecipitated and then blotted for endogenous STAT1 and STAT2. The experiment was repeated twice. (C and D) Immunoblot analysis of ADP-ribosylated STAT1 (C) and STAT2 (D) in PARP7 WT and KO MEF cells. Cells were lysed in the presence of biotin-NAD + or NAD + . Proteins that were ADP-ribosylated by biotin-NAD + were pulled down with streptavidin beads and then blotted for STAT1 or STAT2. Samples treated with NAD + were used as a negative control. Both experiments were repeated three times. (E) PARP7 WT, but not the H532A mutant, ADP-ribosylates STAT1. GFP-tagged empty vector (EV), WT PARP7, or the H532 mutant were co-transfected with FLAG-STAT1 into HEK293T cells. FLAG-STAT1 was pulled down to detect interaction with PARP7 (blotted with GFP antibody) and ADP-ribosylation (blotted with ADP-ribose antibody). The experiment was repeated twice. See also .

Article Snippet: Recombinant human STAT1 (1 μg, MCE #HY- P71335 ) and STAT2 (1 μg, Sinobiological #S53-54G) were incubated with purified GST-PARP7 (0.5 μg) in ADP-ribosylation reaction buffer containing 50 mM Tris-HCl (pH 8.0), 4 mM MgCl 2 , 0.2 mM DTT, and 100 μM NAD + (Sigma-Aldrich).

Techniques: Western Blot, Immunoprecipitation, TNKS1 Histone Ribosylation Assay, Negative Control, Mutagenesis, Plasmid Preparation, Transfection

(A) HEK293T cells were transfected with FLAG-WT or H532A mutant PARP7 overnight. FLAG-PARP7 was detected by immunofluorescence with anti-FLAG (green) antibodies. Endogenous STAT1 was detected by immunofluorescence with Alexa Flour 647. Nuclei were stained with Hoechst stain (blue) (scale bar: 2 μm). Right: quantification of STAT1 and PARP7 co-localization using Pearson’s correlation coefficient. Data are presented as mean ± SD. *** p < 0.001, unpaired t test. (B) HEK293T cells were transfected with FLAG-WT or H532A mutant PARP7 overnight. FLAG-PARP7 was detected by immunofluorescence with anti-FLAG (green) antibodies. Endogenous STAT2 was detected by immunofluorescence with Alexa Flour 647. Nuclei were stained with Hoechst stain (blue) (scale bar: 2 μm.). Right: quantification of STAT2 and PARP7 co-localization using Pearson’s correlation coefficient. Data are presented as mean ± SD. *** p < 0.001, unpaired t test. All experiments were repeated twice. See also .

Journal: Cell reports

Article Title: PARP7 inhibition stabilizes STAT1/STAT2 and relieves experimental autoimmune encephalomyelitis in mice

doi: 10.1016/j.celrep.2025.116130

Figure Lengend Snippet: (A) HEK293T cells were transfected with FLAG-WT or H532A mutant PARP7 overnight. FLAG-PARP7 was detected by immunofluorescence with anti-FLAG (green) antibodies. Endogenous STAT1 was detected by immunofluorescence with Alexa Flour 647. Nuclei were stained with Hoechst stain (blue) (scale bar: 2 μm). Right: quantification of STAT1 and PARP7 co-localization using Pearson’s correlation coefficient. Data are presented as mean ± SD. *** p < 0.001, unpaired t test. (B) HEK293T cells were transfected with FLAG-WT or H532A mutant PARP7 overnight. FLAG-PARP7 was detected by immunofluorescence with anti-FLAG (green) antibodies. Endogenous STAT2 was detected by immunofluorescence with Alexa Flour 647. Nuclei were stained with Hoechst stain (blue) (scale bar: 2 μm.). Right: quantification of STAT2 and PARP7 co-localization using Pearson’s correlation coefficient. Data are presented as mean ± SD. *** p < 0.001, unpaired t test. All experiments were repeated twice. See also .

Article Snippet: Recombinant human STAT1 (1 μg, MCE #HY- P71335 ) and STAT2 (1 μg, Sinobiological #S53-54G) were incubated with purified GST-PARP7 (0.5 μg) in ADP-ribosylation reaction buffer containing 50 mM Tris-HCl (pH 8.0), 4 mM MgCl 2 , 0.2 mM DTT, and 100 μM NAD + (Sigma-Aldrich).

Techniques: Transfection, Mutagenesis, Immunofluorescence, Staining

(A) Western blot analysis of STAT1 and STAT2 in PARP7 WT or KO MEF cells after treatment of MG132 at 20 μМ (left) and cycloheximide (CHX) at 50 μМ (right). The experiment was repeated three times. (B) Western blot analysis of STAT1 and STAT2 in PARP7 WT or KO MEF cells after bafilomycin A1 treatment at 5 μМ. The experiment was repeated three times. (C) coIP analysis of p62 and PARP7 WT or H532A catalytic mutant. FLAG-tagged PARP7 WT and H532A mutant were transfected into HEK293T cells, and coIP was performed to detect interactions between p62 and PARP7 WT or H532A mutant. The experiment was repeated three times. (D) Co-localization of hemagglutinin (HA)-tagged p62 with GFP-tagged PARP7 WT or H532A mutant in HEK293T cells. HA-p62 was detected by immunofluorescence with anti-HA (red) antibody. Nuclei were stained with Hoechst stain (scale bar: 5 μm). The experiment was repeated twice. (E) PARP7 promotes STAT1 and STAT2 ubiquitination. HEK293T cells were co-transfected with FLAG-STAT1 (left) or FLAG-STAT2 (right) and GFP-tagged PARP7 WT or H532A mutant. STAT1 or STAT2 was immunoprecipitated by anti-FLAG affinity resins, and the ubiquitination of STAT1 or STAT2 was analyzed by western blot. The experiment repeated twice. (F) PARP7 promotes p62 interaction with STAT1 and STAT2. HEK293T cells were co-transfected with FLAG-STAT1 (left) or FLAG-STAT2 (right) and GFP-tagged PARP7 WT or H532A mutant. STAT1 or STAT2 was immunoprecipitated by anti-FLAG affinity resin and blotted for p62. The experiment was repeated twice. (G) p62 knockdown diminishes the difference in STAT1 and STAT2 levels between PARP7 WT and KO MEF cells. STAT1 and STAT2 protein levels in PARP7 WT and KO MEF cells with or without p62 knockdown were analyzed by western blots. The experiment was repeated twice. (H) Proposed model depicting the negative regulation of STAT1 and STAT2 by PARP7. PARP7 binds and ADP-ribosylates STAT1 and STAT2. The ADP-ribosylation recruits E3 ubiquitin ligases, leading to the ubiquitination of STAT1 and STAT2. The ubiquitinated STAT1 and STAT2 then recruits p62, leading to autophagy-mediated degradation. Created with BioRender.com . See also – .

Journal: Cell reports

Article Title: PARP7 inhibition stabilizes STAT1/STAT2 and relieves experimental autoimmune encephalomyelitis in mice

doi: 10.1016/j.celrep.2025.116130

Figure Lengend Snippet: (A) Western blot analysis of STAT1 and STAT2 in PARP7 WT or KO MEF cells after treatment of MG132 at 20 μМ (left) and cycloheximide (CHX) at 50 μМ (right). The experiment was repeated three times. (B) Western blot analysis of STAT1 and STAT2 in PARP7 WT or KO MEF cells after bafilomycin A1 treatment at 5 μМ. The experiment was repeated three times. (C) coIP analysis of p62 and PARP7 WT or H532A catalytic mutant. FLAG-tagged PARP7 WT and H532A mutant were transfected into HEK293T cells, and coIP was performed to detect interactions between p62 and PARP7 WT or H532A mutant. The experiment was repeated three times. (D) Co-localization of hemagglutinin (HA)-tagged p62 with GFP-tagged PARP7 WT or H532A mutant in HEK293T cells. HA-p62 was detected by immunofluorescence with anti-HA (red) antibody. Nuclei were stained with Hoechst stain (scale bar: 5 μm). The experiment was repeated twice. (E) PARP7 promotes STAT1 and STAT2 ubiquitination. HEK293T cells were co-transfected with FLAG-STAT1 (left) or FLAG-STAT2 (right) and GFP-tagged PARP7 WT or H532A mutant. STAT1 or STAT2 was immunoprecipitated by anti-FLAG affinity resins, and the ubiquitination of STAT1 or STAT2 was analyzed by western blot. The experiment repeated twice. (F) PARP7 promotes p62 interaction with STAT1 and STAT2. HEK293T cells were co-transfected with FLAG-STAT1 (left) or FLAG-STAT2 (right) and GFP-tagged PARP7 WT or H532A mutant. STAT1 or STAT2 was immunoprecipitated by anti-FLAG affinity resin and blotted for p62. The experiment was repeated twice. (G) p62 knockdown diminishes the difference in STAT1 and STAT2 levels between PARP7 WT and KO MEF cells. STAT1 and STAT2 protein levels in PARP7 WT and KO MEF cells with or without p62 knockdown were analyzed by western blots. The experiment was repeated twice. (H) Proposed model depicting the negative regulation of STAT1 and STAT2 by PARP7. PARP7 binds and ADP-ribosylates STAT1 and STAT2. The ADP-ribosylation recruits E3 ubiquitin ligases, leading to the ubiquitination of STAT1 and STAT2. The ubiquitinated STAT1 and STAT2 then recruits p62, leading to autophagy-mediated degradation. Created with BioRender.com . See also – .

Article Snippet: Recombinant human STAT1 (1 μg, MCE #HY- P71335 ) and STAT2 (1 μg, Sinobiological #S53-54G) were incubated with purified GST-PARP7 (0.5 μg) in ADP-ribosylation reaction buffer containing 50 mM Tris-HCl (pH 8.0), 4 mM MgCl 2 , 0.2 mM DTT, and 100 μM NAD + (Sigma-Aldrich).

Techniques: Western Blot, Mutagenesis, Transfection, Immunofluorescence, Staining, Ubiquitin Proteomics, Immunoprecipitation, Knockdown